secwatch.observer — SEC 8-K summary
======================================

Issuer:     Grace Therapeutics, Inc. (GRCE)
CIK:        0001444192
Form:       8-K
Filed at:   2026-04-27T23:59:59+00:00
Accession:  0001140361-26-016834
Event type: other
Sentiment:  neutral
Materiality: 0.05
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Grace Therapeutics updates corporate presentation in routine 8-K
----------------------------------------------------------------

- Filed an updated corporate presentation as Exhibit 99.1 on April 27, 2026.
- No specific financial or operational changes disclosed in the filing.
- Presentation content not excerpted; unable to identify new information.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1444192/000114036126016834/0001140361-26-016834-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1444192/000114036126016834/ef20071554_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-26-016834

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer